David Pacitti
CIK 1722733 · Chief Executive Officer · last filed 2026-08-14
David Pacitti is a Chief Executive Officer who has filed 19 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing shows the insider had shares withheld for taxes covering $16.6K of OBIO on Aug 14, 2026. Across all open-market trades the lifetime net is −$257.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $317.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
APEN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
CAPITAL OF TEXAS HWY, BLDG. 1, SUITE 300
AUSTIN, TX 78746
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OBIO | Director | 54,750 | $5.80 | $317.8K | $0 | 6 | 2026-08-14 |
| AVANOS MEDICAL, INC. (AVNS) Delisted | Chief Executive Officer | 0 | $24.99 | $0 | $0 | 5 | 2026-07-28 |
| Apollo Endosurgery, Inc. (APEN) Delisted | Director | 0 | $10.00 | $0 | -$257.7K | 8 | 2023-04-04 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-14 | OBIO | Tax (F) | −3,761 | -$16.6K | EDGAR |
| 2026-07-28 | AVANOS MEDICAL, INC. (AVNS) Delisted | Mixed | −322,194 | -$19.17M | EDGAR |
| 2026-06-25 | OBIO | Mixed | +13,543 | $0 | EDGAR |
| 2026-04-16 | AVANOS MEDICAL, INC. (AVNS) Delisted | Tax (F) | −21,194 | -$307.9K | EDGAR |
| 2026-04-01 | AVANOS MEDICAL, INC. (AVNS) Delisted | Grant (A) | +101,341 | $0 | EDGAR |
| 2026-04-01 | AVANOS MEDICAL, INC. (AVNS) Delisted | Grant (A) | +101,341 | $0 | EDGAR |
| 2026-03-17 | AVANOS MEDICAL, INC. (AVNS) Delisted | Grant (A) | +101,341 | $0 | EDGAR |
| 2025-08-08 | OBIO | Grant (A) | +15,000 | $0 | EDGAR |
| 2025-06-26 | OBIO | Grant (A) | +12,422 | $0 | EDGAR |
| 2024-06-21 | OBIO | Grant (A) | +5,376 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.